Working to Eradicate Gynecologic Cancers

Hye Sook Chon, MD

Assistant Member
H. Lee Moffitt Cancer Center
12902 Magnolia drive suite 3057H
Tampa, FL
USA 33612


Biographical Sketch: ASCO poster presentation 2012 SGO plenary session 2010 Chon HS et al. The BCL2 Antagonist of Cell Death (BAD) pathway influences endometrial cancer cell sensitivity to cisplatin. Gynecol Oncol. 2012 Jan;124(1):119-24. Chon HS et al. Targeted therapy in gynecologic cancers. Current Cancer Drug Targets. 2006; 6(4);333-363

Papers:
341 - Poster Session A Association between endometrioid endometrial cancer (EC) risk classification and gene expression in The Cancer Genome Atlas (TCGA) dataset